Mgr. Marek Borský
Researcher, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 4830 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 116
2015
-
Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
Year: 2015, type: Conference abstract
-
Interakce buněk CLL s mikroprostředím vede ke zvýšené expresi CD20 přes chemokinovou dráhu CXCR4/SDF-1: Implikace pro léčbu anti-CD20 protilátkami a BCR-inhibitory.
Year: 2015, type: Conference abstract
-
Microenvironmental interactions up-regulate CD20 expression in CLL B cells through the CXCR4/SDF-1 axis: implications for CD20-targeting antibodies and the use of BCR-inhibitors in combination.
Year: 2015, type: Conference abstract
-
Microenvironmental interactions up-regulate CD20 expressionin CLL B cells, but confer resistance to rituximab
Year: 2015, type: Conference abstract
-
Prognostický význam NOTCH1 murací u chronické lymfocytární leukemie.
Year: 2015, type:
-
Průkaz oligoklonální chronické lymfocytární leukémie u případů s jedinou fenotypově homogenní populací dle průtokové cytometrie - studie na úrovni jednotlivých buněk
Year: 2015, type: Conference abstract
-
Single cell analysis of IG genes in CLL: Cases with multiple IGH rearrangements are constituted of several independent clones even when indistinguishable by flow cytometry.
Year: 2015, type: Conference abstract
-
Single cell analysis proves the coexistence of NOTCH1 and TP53 mutations within the same cancer cells in patients with chronic lymphocytic leukemia
Year: 2015, type: Conference abstract
-
Zvýšená rezistence buněk chronické lymfocytární leukémie s mutací v genu NOTCH1 na ofatumumab in vitro
Year: 2015, type: Conference abstract
2014
-
BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing
American Journal of Hematology, year: 2014, volume: 89, edition: 10, DOI